|
06.03.2023 22:02:00
|
Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference
GAITHERSBURG, Md., March 6, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in TD Cowen's 43rd Annual Health Care Conference.
Conference Details: | ||||||
Fireside Chat | ||||||
Date: | Wednesday, March 8, 2023 | |||||
Time: | 9:50 – 10:20 a.m. Eastern Standard Time (EST) | |||||
Location: | Boston Marriott Copley Place in Boston, Massachusetts | |||||
Moderator: | Georgi Yordanov, Equity Research Analyst – Biotechnology | |||||
Novavax participant: | John Trizzino, Chief Commercial Officer and Chief Business Officer | |||||
Conference | ||||||
Event: | Investor Meetings | |||||
Date: | Wednesday, March 8, 2023 | |||||
Recordings
A replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.
CONTACTS
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Ali Chartan
240-720-7804
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-td-cowens-43rd-annual-health-care-conference-301762705.html
SOURCE Novavax, Inc.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
|
11.11.24 |
Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
|
08.08.24 |
Umsatz von Novavax fällt deutlich - Novavax-Aktie dennoch höher (finanzen.at) | |
|
07.08.24 |
Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.